Largest T cell clinical trial in solid tumors explores potential for precision immunotherapy
The largest ever clinical trial of T cell therapy for solid tumors has ended, heralding a new era for precision T cell ...
manilatimes12h
X4 Pharmaceuticals Announces Positive Results from Completed Six-Month Phase 2 Trial of Mavorixafor in Chronic Neutropenia (CN)
Mavorixafor was generally well tolerated as a monotherapy and in combination with G-CSF, with no drug-related serious adverse ...
sinchew2d
Immuno Cure Biotech Presents Promising Results on Phase I Clinical Trial of a Therapeutic HIV DNA Vaccine
The Phase I Trial data will be submitted to regulatory agencies for review for advancing the vaccine into a Phase II efficacy ...
Targeted Oncology7d
FDA Clears Phase 2 Trial of Leronlimab for Microsatellite-Stable CRC
The FDA recently approved a phase 2 clinical trial to investigate the efficacy of leronlimab in patients with relapsed or ...
Business Wire13d
Ventus Therapeutics Announces Successful Completion of Phase 1 Clinical Trial of VENT-03, a First-in-Class, Orally Administered cGAS Inhibitor
Ventus Therapeutics, a clinical-stage biopharmaceutical company utilizing its proprietary ReSOLVE™ platform to discover and ...
Targeted Oncology2d
FDA Grants Clearance for Phase 1 Trial of BL-M17D1 in Solid Tumors
Following the clearance of an investigational new drug application from the FDA, a phase 1 trial will examine the novel ...
Multiple Sclerosis News Today9d
Dosing begins in early clinical trial of Lucid-MS to protect myelin sheath
A first healthy adults group has been dosed in an early clinical trial of an oral and myelin-protective treatment for all ...
Compass Pathways: Phase 3 Trial Delay - Both Understandable And Disappointing
Compass Pathways' latest update reveals extended trial timelines, staff cuts, and financial concerns, raising questions about ...
MedPage Today7h
Targeted Magnetic Stimulation Slows Alzheimer's Progression in Phase II Study
And also we found the significant effects in terms of ADAS-Cog [Alzheimer's Disease Assessment Scale-Cognitive Subscale], ...
manilatimes12d
The Phase III clinical trial application for first-line treatment of extensive disease small cell lung cancer with Chiauranib has been approved
On November 1, Shenzhen Chipscreen Biosciences Co., Ltd. (hereinafter referred to as 'Chipscreen Biosciences') and its wholly-owned subsidiary Chengdu Chipscreen Pharmaceutical Ltd., received the ...